Financials

  • Market Capitalization 367.58 M
  • Employee 78
  • Founded 2018
  • CEO N/A
  • Website www.centurytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00PM8N5W0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.63
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3090
CTNM
Contineum Therapeutics, Inc. - Common stock
17.05 USD-1.16%+0.29%+17.75%+11.66%393.84 M USD
3107
EYPT
EyePoint, Inc. - Common Stock
4.48 USD-3.24%-13.35%-63.19%-62.67%386.23 M USD
3172
FHTX
Foghorn Therapeutics Inc. - Common Stock
6.00 USD-3.54%-16.90%+26.58%+47.06%356.31 M USD
3173
LYEL
Lyell Immunopharma, Inc. - Common Stock
14.53 USD-0.55%-5.03%+11.94%-39.93%356.06 M USD

Noticias